| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |